• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

85岁及以上患者四肢和躯干壁局限性软组织肉瘤的肿瘤学结局及术后并发症

Oncological Outcomes and Postoperative Complications for Localized Soft Tissue Sarcomas of the Extremities and Trunk Wall in Patients Aged 85 Years or Older.

作者信息

Ikuta Kunihiro, Sakai Tomohisa, Koike Hiroshi, Fujito Takeo, Urakawa Hiroshi, Nishida Yoshihiro, Imagama Shiro

机构信息

Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Japan.

Rare Cancer Center, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya 466-8550, Japan.

出版信息

Cancers (Basel). 2025 Jun 11;17(12):1940. doi: 10.3390/cancers17121940.

DOI:10.3390/cancers17121940
PMID:40563590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12191121/
Abstract

OBJECTIVES

The management of soft tissue sarcoma in patients aged ≥ 85 years remains a clinical dilemma, as evidence to guide treatment decisions in this population is limited. Here, we aimed to compare the clinical characteristics of patients aged ≥ 85 years who underwent surgery with those who did not, to identify factors influencing surgical decision-making. We also assessed the oncological outcomes and postoperative complications in the patients.

METHODS

We reviewed 37 consecutive patients with localized disease involving either the extremities or trunk wall, with a median age of 89.0 years. No significant differences in demographics or clinical characteristics were observed between patients who underwent surgery and those who received conservative management. Among the 37 patients, 25 underwent surgery with curative intent.

RESULTS

The two-year overall survival rate among surgically treated patients was 77%, with local recurrence-free survival and metastasis-free survival rates of 77% and 57%, respectively. Postoperative complications occurred in approximately one-third of the cases. Compared to those without complications, patients with complications were older ( = 0.025), had poorer performance status ( = 0.017), were likely to have trunk involvement ( = 0.01), and had larger tumor sizes ( = 0.025). No significant prognostic factors for overall survival were identified.

CONCLUSIONS

While surgery is not without risk, our results can provide useful information for both physicians and patients to discuss and explain possible outcomes with surgical treatment.

摘要

目的

对于85岁及以上软组织肉瘤患者的管理仍然是一个临床难题,因为指导该人群治疗决策的证据有限。在此,我们旨在比较接受手术治疗的85岁及以上患者与未接受手术治疗患者的临床特征,以确定影响手术决策的因素。我们还评估了这些患者的肿瘤学结局和术后并发症。

方法

我们回顾了37例连续的局限性疾病患者,病变累及四肢或胸壁,中位年龄为89.0岁。接受手术治疗的患者与接受保守治疗的患者在人口统计学或临床特征方面未观察到显著差异。在这37例患者中,25例接受了根治性手术。

结果

接受手术治疗的患者两年总生存率为77%,局部无复发生存率和无转移生存率分别为77%和57%。约三分之一的病例发生了术后并发症。与无并发症的患者相比,有并发症的患者年龄更大(P = 0.025),体能状态更差(P = 0.017),更有可能累及胸壁(P = 0.01),肿瘤尺寸更大(P = 0.025)。未发现影响总生存的显著预后因素。

结论

虽然手术并非没有风险,但我们的结果可为医生和患者讨论并解释手术治疗的可能结局提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f97/12191121/e0fc4b54343c/cancers-17-01940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f97/12191121/7181a2f9fab5/cancers-17-01940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f97/12191121/e0fc4b54343c/cancers-17-01940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f97/12191121/7181a2f9fab5/cancers-17-01940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f97/12191121/e0fc4b54343c/cancers-17-01940-g002.jpg

相似文献

1
Oncological Outcomes and Postoperative Complications for Localized Soft Tissue Sarcomas of the Extremities and Trunk Wall in Patients Aged 85 Years or Older.85岁及以上患者四肢和躯干壁局限性软组织肉瘤的肿瘤学结局及术后并发症
Cancers (Basel). 2025 Jun 11;17(12):1940. doi: 10.3390/cancers17121940.
2
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
5
Postoperative adjuvant chemotherapy in rectal cancer operated for cure.针对接受根治性手术的直肠癌患者的术后辅助化疗。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004078. doi: 10.1002/14651858.CD004078.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
8
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.嵌合抗原受体 (CAR) T 细胞疗法治疗复发或难治性弥漫性大 B 细胞淋巴瘤患者。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
9
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

本文引用的文献

1
Risk factors for serious postoperative complications following gastrectomy in super-elderly patients ≥85-years-old with gastric cancer: A National Clinical Database study in Japan.85岁及以上老年胃癌患者胃切除术后严重并发症的危险因素:日本一项全国临床数据库研究
Ann Gastroenterol Surg. 2024 Jul 10;9(1):79-88. doi: 10.1002/ags3.12843. eCollection 2025 Jan.
2
Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019.日本软组织肉瘤:2016 年至 2019 年国家癌症登记处的分析。
Jpn J Clin Oncol. 2024 Nov 2;54(11):1150-1157. doi: 10.1093/jjco/hyae088.
3
A clinical tool to predict overall survival of elderly patients with soft tissue sarcoma after surgical resection.
一种用于预测接受手术切除的老年软组织肉瘤患者总体生存的临床工具。
Sci Rep. 2024 Jul 2;14(1):15098. doi: 10.1038/s41598-024-65657-2.
4
Postoperative Limb Function and QOL in Elderly Patients With Malignant Bone Tumor/Soft Tissue Sarcoma.老年恶性骨肿瘤/软组织肉瘤患者术后肢体功能和生活质量。
Anticancer Res. 2023 Jul;43(7):3273-3279. doi: 10.21873/anticanres.16502.
5
Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.老年骨肉瘤和软组织肉瘤患者的治疗:日本癌症研究基金会骨和软组织肿瘤研究组。
Jpn J Clin Oncol. 2022 May 31;52(6):526-530. doi: 10.1093/jjco/hyac027.
6
Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma.合并症、体重指数和体能状态作为老年软组织肉瘤患者的预后因素。
J Geriatr Oncol. 2022 Jun;13(5):673-681. doi: 10.1016/j.jgo.2022.02.011. Epub 2022 Feb 24.
7
Treatment Strategy for Elderly Patients with Soft Tissue Sarcoma.老年软组织肉瘤患者的治疗策略。
Curr Oncol Rep. 2022 May;24(5):563-571. doi: 10.1007/s11912-022-01244-w. Epub 2022 Feb 22.
8
Surgical Outcomes of Colorectal Cancer Surgery for ≥ 85-year-old Patients in Our Hospital: Retrospective Comparison of Short- and Long-term Outcomes with Younger Patients.我院≥85岁老年患者结直肠癌手术的外科治疗结果:与年轻患者短期和长期结果的回顾性比较
J Anus Rectum Colon. 2021 Jul 29;5(3):247-253. doi: 10.23922/jarc.2020-095. eCollection 2021.
9
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.软组织和内脏肉瘤:ESMO-EURACAN-GENTURIS诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Nov;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006. Epub 2021 Jul 22.
10
Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses.四肢软组织肉瘤切除术后伤口并发症的风险因素:系统评价和荟萃分析。
J Plast Reconstr Aesthet Surg. 2019 Sep;72(9):1449-1464. doi: 10.1016/j.bjps.2019.05.041. Epub 2019 May 23.